Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Forus Health has developed and commercialized a suite of advanced ophthalmic imaging devices and AI-powered teleophthalmology solutions that have screened over ten million eyes across more than seventy countries. Their technologies enable early detection of retinal diseases such as diabetic retinopathy and ROP, as well as general vision screening in both adults and neonates. The company’s integrated cloud-based platforms support remote diagnosis by connecting patients with specialists worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Forus Health.